Skip to main content
Log in

Virale Pneumonie

Viral pneumonias

  • Leitthema
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

Zusammenfassung

Viren sind für bis zu 35% der ambulant erworbenen Pneumonien v. a. im frühen Kindesalter verantwortlich. Neben den klassischen Erregern [RS- („respiratory syncytial“), Influenza-A- und -B-, Parainfluenza-, Adeno- und Rhinoviren)] wurden in den letzten 10 Jahren 3 neue Viren beschrieben, humanes Metapneumovirus (hMPV), humanes Bocavirus (hBoV) und H1N1. Klinisch ähnelt die hMPV-Infektion im Verlauf einer RSV-Infektion, bei hospitalisierter hBoV-Pneumonie findet sich häufig eine Sauerstoffpflichtigkeit, H1N1 führt zu einer selbstlimitierenden Krankheit, welche im Verlauf einer saisonalen Influenza ähnelt. Fieber, Tachydyspnoe und feinblasige Rasselgeräusche sind die wegweisenden Symptome. Akute-Phase-Parameter [großes Blutbild, C-reaktives Protein (CRP), Blutsenkungsgeschwindigkeit (BSG) und Prokalzitonin] differenzieren nicht zuverlässig zwischen viraler/bakterieller Genese und sollten schwereren Fällen vorbehalten bleiben. Ein Röntgenbild der Lunge empfiehlt sich bei diagnostisch unklaren Fällen oder beim Verdacht auf Komplikationen. In der Regel sind die Verläufe mild, und eine symptomatische Therapie mit Analgetika, Antipyretika und genügender Flüssigkeitszufuhr reicht aus. Wichtige Komplikationen sind obstruktive Ventilationsstörungen (O2-Monitoring) und Apnoen (v. a. bei Säuglingen <1 Monat).

Abstract

Viral pneumonias account for approximately 35% of community acquired pneumonia, especially in early childhood. In addition to respiratory syncytial virus (RSV), influenza A/B, parainfluenza, adeno- and rhinovirus, three new viruses have been described: human metapneumovirus (hMPV), human bocavirus (hBoV) and H1N1. hMPV shares many characteristics with RSV; oxygen supplementation is often needed in children hospitalized for hBoV pneumonia, while H1N1 pneumonia is a self-limiting disease resembling the course of seasonal influenza. Fever, tachydyspnea und rales are typical clinical symptoms. Acute phase reactants (WBC, CRP, BSR and procalcitonin) do not distinguish between bacterial and viral infections and should not be measured routinely. Chest radiography should be performed if etiology is unclear and if complications (atelectasis etc.) are suspected. In general, the clinical course of viral pneumonia is mild and symptomatic treatment with antipyretics/analgetics and adequate hydration is sufficient. Wheezing (monitoring for oxygen saturation) and apnea (particularly in infants <1 month) represent relevant complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Allander T, Tammi MT, Eriksson M et al (2005) Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 102(36):1291–1296

    Article  Google Scholar 

  2. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis (2006) Diagnosis and management of bronchiolitis. Pediatrics 118:1774–1793

    Article  Google Scholar 

  3. Blom D, Ermers M, Bont L et al (2007) Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev 1:CD004881

    PubMed  Google Scholar 

  4. Chetty K, Thomson AH (2007) Management of community-acquired pneumonia in children. Paediatr Drugs 9(6):401–404

    Article  PubMed  Google Scholar 

  5. Cilla G, Onate E, Perez-Yarza EG et al (2008) Viruses in community-acquired pneumonia in children aged less than 3 years old: high rate of viral coinfection. J Med Virol 80:1843–1849

    Article  PubMed  Google Scholar 

  6. Crowe JE (2004) Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr Infect Dis J 23:S215–S221

    Article  PubMed  Google Scholar 

  7. Deutsche Gesellschaft für pädiatrische Infektiologie (DGPI) (2009) Ausführungen zu Diagnostik und Therapie: Aktualisierte Empfehlung der DGPI zur Diagnostik, Therapie und Prophylaxe der Infektion mit der Neuen Influenza A/H1N1v-Virus bei Kindern und Jugendlichen, Stand 09.11.2009. DGPI, Bremen, www.dgpi.de/pdf/InflA%20_H1N1v_DGPI-Empfehlungen_09Nov2009.pdf

  8. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI), Deutsche Gesellschaft für Pädiatrische Kardiologie (DGPK), Gesellschaft für Pädiatrische Pneumologie (GPP) und Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin (GNPI) (2009) RSV-Prophylaxe mit Palivizumab bei Risikokindern – Aktualisierte Leitlinie 2008. Monatschr Kinderheilkd 157:61–64

    Article  Google Scholar 

  9. Don M, Fasoli L, Paldanius M et al (2005) Aetiology of community-acquired pneumonia: serological results of a paediatric survey. Scand J Infect Dis 37:806–812

    Article  PubMed  Google Scholar 

  10. Don M, Canciani M, Korppi M (2010) Community acquired pneumonia in children: what’s old? What’s new? Acta Paediatr 99:1602–1608

    Article  PubMed  Google Scholar 

  11. Don M, Soderlund-Vermo M, Valent F et al (2010) Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol 45:120–126

    Article  PubMed  Google Scholar 

  12. Fry AM, Lu X, Chittaganptich M et al (2007) Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis 195:1038–1045

    Article  PubMed  Google Scholar 

  13. Gilsdorf A, Poggensee G; Working Group Pandemic Influenza A(H1N1)v (2009) Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill 14(34):1–4

    Google Scholar 

  14. Ginocchio CG, Zhang F, Manji R et al (2009) Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 45:191–195

    Article  PubMed  CAS  Google Scholar 

  15. Groll AH, Werner C, Tebbe J et al (2011) Pulmonale Infektionen in der pädiatrischen Hämatologie und Onkologie. Monatsschr Kinderheilkd 3

  16. Hoogen BG van den, Jong JC de, Groen J et al (2001) A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7:719–724

    Article  PubMed  Google Scholar 

  17. Hoogen BG van den, Osterhaus DM, Fouchier RA et al (2004) Clinical impact and diagnosis of human metapneumovirus infection. Pediatr Infect Dis J 23:S25–S32

    Article  PubMed  Google Scholar 

  18. Jadavji T, Law B, Lebel MH et al (1997) A practical guide for the diagnosis and treatment of pediatric pneumonia. Can Med Assoc J 156:S703–S711

    CAS  Google Scholar 

  19. Juven T, Mertsola J, Waris M et al (2000) Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis 19:293–298

    Article  CAS  Google Scholar 

  20. Kahn JS, Kesebir D, Cotmore SF et al (2008) Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis 198:41–50

    Article  PubMed  CAS  Google Scholar 

  21. Kumar P, McKean MC (2004) Evidence based paediatrics: review of BTS guidelines for the management of community acquired pneumonia in children. J Infect 48:134–138

    Article  PubMed  CAS  Google Scholar 

  22. Lahti E, Peltola V, Waris M et al (2009) Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax 64(3):252–257

    Article  PubMed  CAS  Google Scholar 

  23. Leung J, Esper F, Weibel C et al (2005) Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing HMPV fusion protein expressed in recombinant vesicular stomatitis virus. J Clin Microbiol 43:1213–1219

    Article  PubMed  CAS  Google Scholar 

  24. Papadopoulos NG, Christodoulou I, Rohde G et al (2010) Viruses and bacteria in acute asthma exacerbations – A GA(2) LEN-DARE* systemic review. Allergy Nov 18. [Epub ahead of print]. DOI 10.1111/j.1398-9995.2010.02505

  25. RKI (2010) Rückblick: Epidemiologie und Infektionsschutz im zeitlichen Verlauf der Influenzapandemie (H1N1) 2009. Epidemiol Bull 21:191–201

    Google Scholar 

  26. Söderlund-Venermo M, Lahtinen A, Jartti T et al (2009) Human bocavirus infection in children with acute wheezing: comparison of serology and PCR in diagnosis and analysis of the clinical profile. Emerg Infect Dis 15:1423–1430

    Article  PubMed  Google Scholar 

  27. Ständige Impfkommission (STIKO) am Robert Koch-Institut (2010) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2010. Epidemiol Bull 30:279–298

    Google Scholar 

  28. Toikka P, Irjala K, Juvén T et al (2000) Serum procalcitonin, C-reactive protein, and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 19(7):598–602

    Article  PubMed  CAS  Google Scholar 

  29. Virkki R, Juten T, Rikalainen K et al (2002) Differentiation of bacterial and viral pneumonia in children. Thorax 57:438–441

    Article  PubMed  CAS  Google Scholar 

  30. Völz S, Schildgen O, Klinkenberg D et al (2007) Prospective study of human bocavirus (HBoV) infection in a pediatric university hospital in Germany 2005/2006. J Clin Virol 40:229–235

    Article  PubMed  Google Scholar 

  31. Wilkesmann A, Schildgen O, Eis-Hübinger AM et al (2006) Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr 165:467–475

    Article  PubMed  Google Scholar 

  32. Williams JV, Harris PA, Tollefson SJ et al (2004) Human metapneumovirus and lower respiratory tract diesease in otherwise healthy infants and children. N Engl J Med 350:443–450

    Article  PubMed  CAS  Google Scholar 

  33. Wright M, Piedimonte G (2010) Respiratory syncytial virus prevention and therapy: past, present and future. Pediatr Pulmonol Nov 23. [Epub ahead of print]

  34. Zhang L, Mendoza-Sassi RA, Wainwright C et al (2008) Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 4:CD006458

    PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Schmitt-Grohé.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmitt-Grohé, S. Virale Pneumonie. Monatsschr Kinderheilkd 159, 217–223 (2011). https://doi.org/10.1007/s00112-010-2302-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-010-2302-5

Schlüsselwörter

Keywords

Navigation